Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients
- 29 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Pharmacy
- Vol. 43 (1), 128-136
- https://doi.org/10.1007/s11096-020-01117-x
Abstract
Background Several anticholinergic scales and equations to evaluate the anticholinergic burden have been previously created. Association of these instruments with the anticholinergic outcomes are usually estimated by means of hypothesis contrast tests, which ignore the size of the association effect. Objective To evaluate the effect size of the associations between the scores on cumulative anticholinergic burden instruments with peripheral or central anticholinergic adverse outcomes in older patients. Setting Internal medicine ward of a Tertiary University Hospital. Methods A case–control study was conducted in patients over 65 years who were admitted to two internal medicine wards of a Portuguese university hospital. The Anticholinergic Drug Scale, Anticholinergic Risk Scale, Anticholinergic Cognitive Burden scale and Drug Burden Index were used to calculate the patients’ anticholinergic burden. Peripheral (dry mouth—swab technique; dry eye—Schirmer test) and central (falls and cognitive impairment—Mini-Mental State Examination) anticholinergic adverse outcomes were investigated. The Barthel Index was used to assess overall physical functionality. The Mann–Whitney test was used to evaluate probabilistic differences in the anticholinergic scores between case and control individuals. To establish the effect size of the associations, the area under the curve of the receiver operating characteristics curve was calculated. Main outcome measure Anticholinergic adverse effects. Results A total of 250 patients (mean age 81.67 years, standard deviation 7.768; 50% females) were included. In total, 148 patients (59.2%) presented with dry mouth, 85 (34%) with dry eye, 141 (56.4%) with impaired functionality, 44 (17.6%) with a history of falls and 219 (87.6%) with cognitive impairment. Significant differences (p < 0.05) were obtained for the majority of the associations between Anticholinergic Drug Scale, Anticholinergic Risk Scale, Anticholinergic Cognitive Burden and Drug Burden Index and adverse effects. Conversely, the effect sizes of these associations ranged from “fail” (area under the curve 0.5 to 0.6) to “fair” (area under the curve 0.7 to 0.8). Conclusion Although significant differences in the scores of anticholinergic burden instruments and adverse outcomes may exist, the effect sizes of these associations ranged from ‘fail’ to ‘fair’, which limits their utility in preventing anticholinergic adverse outcomes with medication review interventions.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/123678/2016)
This publication has 40 references indexed in Scilit:
- Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homesBritish Journal of Clinical Pharmacology, 2013
- Cognitive Effects of Reducing Anticholinergic Drug Burden in a Frail Elderly Population: A Randomized Controlled TrialThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- A systematic review of methods to diagnose oral dryness and salivary gland functionBMC Oral Health, 2012
- Effects of Drug Burden Index on Cognitive Function in Older MenJournal of Clinical Psychopharmacology, 2012
- Drug Burden Index Score and Functional Decline in Older PeopleThe American Journal of Medicine, 2009
- Drug Burden Index and physical function in older Australian menBritish Journal of Clinical Pharmacology, 2009
- The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older PersonsArchives of Internal Medicine, 2008
- A Drug Burden Index to Define the Functional Burden of Medications in Older PeopleArchives of Internal Medicine, 2007
- Assessment of Salivary Flow Rate: Biologic Variation and Measure ErrorThe Laryngoscope, 2004
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975